Close

Teva Pharma (TEVA) Announces U.S. Launch of Generic Avodart

October 12, 2015 8:34 AM EDT Send to a Friend
Teva Pharma (NYSE: TEVA) announced the exclusive launch of the generic equivalent to AvodartĀ® (dutasteride) capsules, 0.5 mg, in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login